Patients First: Reducing Stigma and Applying Harm Reduction - Part II Ethics and Communication

November 7, 2019 - November 6, 2020

Patients First: A Practical Approach to Reducing Stigma and Applying Harm Reduction to Pharmacy Practice

Harm Reduction II – Ethics and Communication


Target Audience: 

Only open to Alberta pharmacists registered with the Alberta College of Pharmacy. 


This session will benefit any pharmacist regardless of their practice setting.



This presentation explores some issues pharmacists might face related to substance use and harm reduction. This harm reduction focused program is aimed at helping pharmacists learn about the ethical implications of harm reduction and how to identify implications for practice. As well, you will learn about relationship-centred care principles and how to apply them to clinical interactions with people who use drugs.



Helgi Eyford PhD, Ginetta Salvalaggio MD, MSc, CCFP


Helgi Eyford, PhD is a clinical ethicist with AHS. He works at the Peter Lougheed Centre with homecare and long-term care and with the addiction and mental health portfolios within AHS.


Dr. Salvalaggio is an Associate Professor with the University of Alberta Department of Family Medicine, and the Associate Scientific Director of the Inner City Health and Wellness Program. She received her degree in Medicine from the University of Alberta and completed a family practice residency in Thunder Bay, Ontario.  Initially practicing as a rural locum, she eventually returned to Edmonton to establish a maternity care and family practice. Dr. Salvalaggio joined the Department of Family Medicine in 2007. She has also completed a Masters of Science in Population Health through the University of Alberta School of Public Health. Her academic interests are focused on social accountability, patient and community engagement, and health services for urban underserved populations. 



At the end of this session you should be able to:

  • Explain the concept of harm reduction
  • Discuss the ethical justification for harm reduction and identify implications for practice
  • Use harm reduction as a framework for providing care
  • Apply relationship-centred care principles to clinical interactions involving people who use drugs



CCCEP Program #: 8007-2019-2926-I-P

Expires: November 6, 2020

CEU’s:  1.0

Attendees will receive a Statement of Attendance following the successful completion of the post-exam.  A score of 70% or greater is required on the post-exam.



Registration for this course will grant you access to the presentation and materials for a period of 90 days.  Please ensure you complete the course within 90 days of registering.



RxA Member Fee:             $0.00 (no charge)

Non-member Fee:            $75.00

The value of this course is $100


Please contact the Alberta Pharmacists' Association at if you have questions about this session.


Cancellation and Refunds: 
Not applicable. 


RxE-MEMBER AdvantageTM program for Non-Members included in your registration fee.

Every Non-Member that registers for this program will receive a $50.00 RxE-MEMBER AdvantageTM credit* that they can use towards the purchase of their RxA membership for the NEXT membership year.  This incentive is part of a program RxA is offering to encourage all pharmacists to become a member of RxA.  

For more about the RxE-MEMBER AdvantageTM program click here. 


Difficulty Registering Online? 

Download our registration form, fill it out, and fax it back to us at 780-990-1236.

We'll process it the next business day and you'll receive a confirmation by e-mail. 


Only open to Alberta pharmacists registered with the Alberta College of  Pharmacy  

Member Fee:  $0.00
Student Fee:  $0.00
Non-Member Fee:  $75.00